M&T Bank Corp Has $12.40 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

M&T Bank Corp reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 32.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 112,361 shares of the medical device company’s stock after selling 55,177 shares during the period. M&T Bank Corp owned approximately 0.06% of Cooper Companies worth $12,399,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in COO. Point72 Asset Management L.P. raised its stake in shares of Cooper Companies by 480.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after purchasing an additional 776,140 shares during the period. Victory Capital Management Inc. boosted its position in Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares during the last quarter. Magnetar Financial LLC bought a new position in shares of Cooper Companies during the 2nd quarter worth approximately $63,822,000. TD Asset Management Inc acquired a new stake in shares of Cooper Companies in the second quarter valued at approximately $53,045,000. Finally, Impax Asset Management Group plc lifted its position in shares of Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after purchasing an additional 558,886 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of several analyst reports. Robert W. Baird boosted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Citigroup decreased their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Piper Sandler upped their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley dropped their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Performance

NASDAQ:COO opened at $93.44 on Friday. The stock has a 50 day simple moving average of $102.20 and a 200 day simple moving average of $98.89. The stock has a market cap of $18.65 billion, a P/E ratio of 47.92, a PEG ratio of 2.52 and a beta of 0.97. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the company posted $0.87 earnings per share. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.